Press Release / Dec 04, 2017
Hovione Announces Enrollment of First Patient in MARS
A Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Biodegradable PLGA-based microspheres present a valuable vehicle for drug transportation, and their use in controlled release opens doors for developers and manufacturers